Oncopeptides AB (publ) (LON:0RN4)
1.700
-0.014 (-0.82%)
At close: Jul 7, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 38.68 million as of July 9, 2025. Its market cap has decreased by -16.88% in one year.
Market Cap
38.68M
Enterprise Value
40.68M
Revenue
3.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 38.68M, a decrease of -74.05%. That is a compound annual growth rate of -14.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 160.28B |
Shell | 155.15B |
HSBC Holdings | 153.72B |
Unilever | 112.24B |
Rolls-Royce Holdings | 80.35B |
British American Tobacco p.l.c. | 77.53B |
Rio Tinto Group | 72.88B |
RELX PLC | 71.39B |